The expression of the O-linked N-acetylglucosamine containing epitope H in the gemistocytic, pilocytic and subependymal giant cell astrocytomas

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 521-524

  Arvanitis, Leonidas D ^a,c   Koukoulis, George K ^a   Kanavaros, Panagiotis ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c RUSH UNIVERSITY   (United States)

Author keywords

Astrocytoma; Epitope H; Monoclonal antibody H

Indexed keywords

EPITOPE; EPITOPE H; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H; N ACETYLGLUCOSAMINE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CONTROLLED STUDY; GEMISTOCYTIC ASTROCYTOMA; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; NULL ALLELE; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; SUBEPENDYMAL GIANT CELL ASTROCYTOMA; TUBEROUS SCLEROSIS; BRAIN TUMOR; CHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY;

ACETYLGLUCOSAMINE; ASTROCYTOMA; BRAIN NEOPLASMS; EPITOPES; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 70349326052     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000466     Document Type: Article

References (28)

1. Kleihues P and Cavenee WK: World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system, International Agency for Research on Cancer. IARC Press, Lyon, 2000.
2. Collins VP: Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry 75 (Suppl. 2): 2-11, 2004.
3. Gladson CL: The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58: 1029-1040, 1999.
4. Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M and Yamaura A: Molecular classification and survival prediction in human gliomas based on proteosome analysis. Cancer Res 64: 2496-2501, 2004.
5. Zamecnik J, Vargova L, Homola A, Kodet R and Sykova E: Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol Appl Neurobiol 30: 338-350, 2004.
6. Zanetta JP: Structure and functions of lectins in the central and peripheral nervous system. Acta Anat 161: 180-195, 1998.
7. Yates AJ, Comas T, Scheithauer BW, Burger PC and Pearl DK: Glycolipid markers of astrocytomas and oligodendrogliomas. J Neuropathol Exp Neurology 58: 1250-1262, 1999.
8. Arvanitis DL, Stavridou AI, Mori de Moro G and Szuchet S: Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res 304: 11-19, 2001.
9. Hart GW: Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66: 315-335, 1997.
10. Zachara NE and Hart GW: The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 102: 431-438, 2002.
11. Zachara NE and Hart GW: O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochem Biophys Acta 1673: 13-28, 2004.
12. Jackson SP and Tjian R: Purification and analysis of RNA polymerase II transcription factors by using wheat germ agglutinin affinity chromatography. Proc Natl Acad Sci USA 86: 1781-1785, 1989.
13. Privalsky ML: A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated. J Virol 64: 463-466, 1990.
14. Chou TY, Hart GW and Dang CV: C-myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-18965, 1995.
15. Shaw P, Freeman J, Bovey R and Iggo R: Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene 12: 921-930, 1996.
16. Haltiwagner RS, Busby S and Grove K: O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation? Biochem Biophys Res Commun 231: 237-242, 1997.
17. Kreppel LK, Blomberg MA and Hart GW: Dynamic glycosylation of nuclear and cytosolic proteins. J Biol Chem 272: 9308-9315, 1997.
18. Van den Steen P, Rudd PM, Dwek RA and Opdenakker G: Concepts and principles of O-linked glycosylation. Crit Rev Mol Biol 33: 151-208, 1998.
19. Miller MW, Caracciolo MR, Berlin WK and Hanover JA: Phosphorylation and glycosylation of nucleoporins. Arch Biochem Biophys 367: 51-60, 1999.
20. Chou TY and Hart GW: O-linked N-acetyl glycosamine and cancer: messages from the glycosylation of c-myc. Adv Exp Med Biol 491: 413-418, 2001.
21. Arvanitis DL, Kouklis P, Mori de Moro G, Goutas N, Kittas C and Szuchet S: Immunostaining of ductal breast carcinomas with the monoclonal antibody H. Oncol Rep 2: 991-995, 1995.
22. Havaki S, Kittas C, Marinos E, Dafni U, Sotiropoulou C, Voloudakis-Baltatzis I, Goutas N, Vassilaros SD, Athanassiou E and Arvanitis DL: Ultrastructural immunostaining of infiltrating ductal breast carcinomas with the monoclonal antibody H: a comparative study with cytokeratin 8. Ultrastructural Pathol 27: 393-407, 2003.
23. Arvanitis DL, Arvanitis LD, Panourias IG, Kitsoulis P and Kanavaros P: Mitochondria-rich normal, metaplastic and neoplastic cells show overexpression of the epitope H recognized by the monoclonal antibody H. Pathol Res Pract 21: 319-324, 2005.
24. Arvanitis DL, Arvanitis LD, Panourias IG, Kitsoulis P and Kanavaros P: The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas. Histol Histopathol 20: 1057-1063, 2005.
25. Polyzos P.T., Arvanitis LD, Charchanti A, Galani V, Havaki S, Kallioras VA, Nakou M, Faros EG, Marinos E, Sgantzos MN and Kittas C: Decidualized and pre-decidualized normal endometrial stromal cells produce more O-linked N-acetylglucosamine containing epitope H than non-decidualized normal endometrial stromal cells. Histol Histopathol Vol:21,Iss:10-12,Pages:1193-1198, 2006.
26. Sgantzos MN, Galani V, Arvanitis LD, Charchanti A, Psathas P, Nakou M, Havaki S, Kallioras V, Marinos E, Vamvakopoulos NC and Kittas C: Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Pathol Res Pract 203: 31-37, 2007.
27. Wells L, Whelan SA and Hart GW: O-GlcNAc: a regulatory post-translational modification. Biochem Biophys Res Com 302: 435-441, 2003.
28. Sanchez-Beato M, Sanchez-Aguilera A and Piris MA: Cell cycle deregulation in B-cell lymphomas. Blood 101: 1220-1235, 2003.